Krynica Vitamin S.A. (WSE: KVT)

Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 119.09 million. The enterprise value is 168.61 million.

Market Cap	119.09M
Enterprise Value	168.61M

Important Dates

The next estimated earnings date is Monday, November 25, 2024.

Earnings Date	Nov 25, 2024
Ex-Dividend Date	n/a

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	12.25M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.92%
Float	1.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.31
PB Ratio	1.37
P/TBV Ratio	n/a
P/FCF Ratio	18.95
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.41, with an EV/FCF ratio of 26.83.

EV / Earnings	-47.78
EV / Sales	0.44
EV / EBITDA	6.41
EV / EBIT	13.43
EV / FCF	26.83

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.63.

Current Ratio	0.86
Quick Ratio	0.49
Debt / Equity	0.63
Debt / EBITDA	2.07
Debt / FCF	8.65
Interest Coverage	3.03

Financial Efficiency

Return on equity (ROE) is -3.99% and return on invested capital (ROIC) is 5.55%.

Return on Equity (ROE)	-3.99%
Return on Assets (ROA)	3.33%
Return on Capital (ROIC)	5.55%
Revenue Per Employee	1.15M
Profits Per Employee	-10,503
Employee Count	336
Asset Turnover	1.64
Inventory Turnover	7.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.92% in the last 52 weeks. The beta is -0.19, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-26.92%
50-Day Moving Average	10.01
200-Day Moving Average	11.22
Relative Strength Index (RSI)	44.66
Average Volume (20 Days)	1,270

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 387.34 million and -3.53 million in losses. Loss per share was -0.29.

Revenue	387.34M
Gross Profit	59.54M
Operating Income	12.56M
Pretax Income	-2.78M
Net Income	-3.53M
EBITDA	26.29M
EBIT	12.56M
Loss Per Share	-0.29

Balance Sheet

The company has 4.84 million in cash and 54.36 million in debt, giving a net cash position of -49.52 million or -4.04 per share.

Cash & Cash Equivalents	4.84M
Total Debt	54.36M
Net Cash	-49.52M
Net Cash Per Share	-4.04
Equity (Book Value)	86.73M
Book Value Per Share	7.08
Working Capital	-16.67M

Cash Flow

In the last 12 months, operating cash flow was 16.97 million and capital expenditures -10.68 million, giving a free cash flow of 6.28 million.

Operating Cash Flow	16.97M
Capital Expenditures	-10.68M
Free Cash Flow	6.28M
FCF Per Share	0.51

Margins

Gross margin is 15.37%, with operating and profit margins of 3.24% and -0.91%.

Gross Margin	15.37%
Operating Margin	3.24%
Pretax Margin	-0.72%
Profit Margin	-0.91%
EBITDA Margin	6.79%
EBIT Margin	3.24%
FCF Margin	1.62%

Dividends & Yields

Krynica Vitamin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.03%
Earnings Yield	-2.96%
FCF Yield	5.28%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Krynica Vitamin has an Altman Z-Score of 2.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.37
Piotroski F-Score	n/a